VVX Stock Analysis: V2X | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 2.200m USD | 12M Return: 26.1% | US92242T1016 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 27.8M
EPS Trend: 96.4%
Qual. Beats: 3
Rev. Trend: 97.5%
Qual. Beats: 2
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
V2X, Inc. (NYSE: VVX) is a U.S.-based provider of critical mission solutions and support services to defense customers worldwide. The company delivers integrated offerings spanning multi-domain mission readiness, supply chain management, platform modernization, and national security programs for defense, civilian, and international clients. Incorporated in 2014 and headquartered in Reston, Virginia, V2X operates as a subsidiary of Vertex Aerospace Holdco LLC. The company went public in July 2022 and is classified within the Industrials sector, specifically the Aerospace & Defense sub-industry, with a mid-cap market valuation.
As a defense services contractor, V2X earns revenue primarily through long-term government contracts, particularly with the U.S. Department of Defense, which often provides revenue visibility and stability. The aerospace and defense sector is heavily influenced by geopolitical tensions, U.S. federal defense budgets, and allied military spending, and V2Xs mission-critical support positioning aligns it with these enduring demand drivers. Its services-oriented business model, rather than relying on major platform manufacturing, differentiates it from large prime defense contractors and exposes it more to sustainment, logistics, and modernization spending cycles.
- DoD budget growth expands V2X mission solutions backlog
- International defense contracts diversify revenue base
- Margin expansion driven by operational efficiency gains
| Net Income: 91.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -2.61 > 1.0 |
| NWC/Revenue: 5.94% < 20% (prev 4.17%; Δ 1.78% < -1%) |
| CFO/TA 0.04 > 3% & CFO 140.6m > Net Income 91.8m |
| Net Debt (882.9m) to EBITDA (312.1m): 2.83 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.5m) vs 12m ago -1.13% < -2% |
| Gross Margin: 8.47% > 18% (prev 8.60%; Δ -0.13% > 0.5%) |
| Asset Turnover: 154.4% > 50% (prev 137.8%; Δ 16.60% > 0%) |
| Interest Coverage Ratio: 2.45 > 6 (EBIT TTM 197.7m / Interest Expense TTM 80.5m) |
| A: 0.09 (Total Current Assets 1.21b - Total Current Liabilities 914.4m) / Total Assets 3.20b |
| B: 0.12 (Retained Earnings 387.9m / Total Assets 3.20b) |
| C: 0.06 (EBIT TTM 197.7m / Avg Total Assets 3.17b) |
| D: 0.55 (Book Value of Equity 1.13b / Total Liabilities 2.06b) |
| Altman-Z'' = 1.99 = BBB |
| DSRI: 0.99 (Receivables 827.4m/738.9m, Revenue 4.90b/4.33b) |
| GMI: 1.02 (GM 8.60% / 8.47%) |
| AQI: 0.96 (AQ_t 0.61 / AQ_t-1 0.63) |
| SGI: 1.13 (Revenue 4.90b / 4.33b) |
| TATA: -0.02 (NI 91.8m - CFO 140.6m) / TA 3.20b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of October 23, 2026, the stock is trading at USD 73.36 with a total of 348,377 shares traded. Over the past week, the price has changed by +6.94%, over one month by +0.56%, over three months by -9.43% and over the past year by +26.07%.
Current recommended Stop Loss: 67.90 (which is 7.4% or 2.2 ATR below the current price).
V2X has received a consensus analysts rating of 3.58. Therefore, it is recommended to hold VVX.
- StrongBuy: 4
- Buy: 1
- Hold: 6
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 88.9 | 21.2% |
P/E Trailing = 24.1966
P/E Forward = 11.1359
P/S = 0.4492
P/B = 2.0706
Revenue TTM = 4.90b USD
EBIT TTM = 197.7m USD
EBITDA TTM = 312.1m USD
Long Term Debt = 1.05b USD (from longTermDebt, last quarter)
Short Term Debt = 16.1m USD (from shortTermDebt, last quarter)
Debt = 1.10b USD (from shortLongTermDebtTotal, last quarter) + Leases 33.2m
Net Debt = 882.9m USD (calculated: Debt 1.10b - CCE 214.3m)
Enterprise Value = 3.08b USD (2.20b + Debt 1.10b - CCE 214.3m)
Interest Coverage Ratio = 2.45 (Ebit TTM 197.7m / Interest Expense TTM 80.5m)
EV/FCF = 23.63x (Enterprise Value 3.08b / FCF TTM 130.4m)
FCF Yield = 4.23% (FCF TTM 130.4m / Enterprise Value 3.08b)
FCF Margin = 2.66% (FCF TTM 130.4m / Revenue TTM 4.90b)
Net Margin = 1.88% (Net Income TTM 91.8m / Revenue TTM 4.90b)
Gross Margin = 8.47% ((Revenue TTM 4.90b - Cost of Revenue TTM 4.48b) / Revenue TTM)
Gross Margin QoQ = 8.71% (prev 8.44%)
Tobins Q-Ratio = 0.96 (Enterprise Value 3.08b / Total Assets 3.20b)
Interest Expense / Debt = 7.34% (Interest Expense 80.5m / Debt 1.10b)
Taxrate = 22.25% (26.3m / 118.1m)
NOPAT = 153.7m (EBIT 197.7m * (1 - 22.25%))
Current Ratio = 1.32 (Total Current Assets 1.21b / Total Current Liabilities 914.4m)
Debt / Equity = 0.97 (Debt 1.10b / totalStockholderEquity, last quarter 1.13b)
Debt / EBITDA = 2.83 (Net Debt 882.9m / EBITDA 312.1m)
Debt / FCF = 6.77 (Net Debt 882.9m / FCF TTM 130.4m)
Total Stockholder Equity = 1.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.90% (Net Income 91.8m / Total Assets 3.20b)
RoE = 8.35% (Net Income TTM 91.8m / Total Stockholder Equity 1.10b)
RoCE = 9.20% (EBIT 197.7m / Capital Employed (Equity 1.10b + L.T.Debt 1.05b))
RoIC = 7.37% (NOPAT 153.7m / Invested Capital 2.09b)
WACC = 6.39% (E(2.20b)/V(3.30b) * Re(6.73%) + D(1.10b)/V(3.30b) * Rd(7.34%) * (1-Tc(0.22)))
Discount Rate = 6.73% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -30.07 | Cagr: -0.38%
[DCF] Terminal Value 73.10% ; FCFF base≈162.4m ; Y1≈142.4m ; Y5≈115.1m
[DCF] Fair Price = 30.76 (EV 1.85b - Net Debt 882.9m = Equity 964.3m / Shares 31.3m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 96.43 | EPS CAGR: 50.52% | SUE: 1.65 | # QB: 3
Revenue Correlation: 97.51 | Revenue CAGR: 7.62% | SUE: 1.12 | # QB: 2
EPS current Quarter (2026-09-30): EPS=1.49 | Chg30d=-0.10% | Revisions=+25% | Analysts=11
EPS current Year (2026-12-31): EPS=6.23 | Chg30d=-0.01% | Revisions=+25% | GrowthEPS=+18.8% | GrowthRev=+11.1%
EPS next Year (2027-12-31): EPS=6.94 | Chg30d=+0.05% | Revisions=+25% | GrowthEPS=+11.5% | GrowthRev=+5.3%
[Analyst] Revisions Ratio: +50% (up=3, down=0)